Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer

Citation

Wilkinson, B, Day, S, Malins, L et al 2011, 'Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer', Angewandte Chemie International Edition, vol. 50, pp. 1635-1639.

Year

2011

ANU Authors

Field of Research

  • Organic Chemical Synthesis

Updated:  20 May 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers